Balyasny Asset Management L.P. Invests $256,000 in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Balyasny Asset Management L.P. bought a new position in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund bought 12,921 shares of the company’s stock, valued at approximately $256,000. Other large investors have also recently made changes to their positions in the company. JPMorgan Chase & Co. grew its […]
